Arca
Skip to content
Tools
Tools

RNA-directed RNA polymerase

Complex in Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on PA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Favipiravir

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        FavipiravirApprovedMdvi, LLCSmall moleculeInhibitorRNA-directed RNA polymerase inhibitor7

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 7 in all, from ClinicalTrials.gov.
        UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHFFavipiravirPhase 2RecruitingLiverpool School of Tropical MedicineMar 6, 2025
        Assessing Antiviral Treatments in Early Symptomatic RSVFavipiravirPhase 2RecruitingUniversity of OxfordJul 5, 2024
        ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyFavipiravirPhase 2 / Phase 3RecruitingIrrua Specialist Teaching HospitalJan 18, 2024
        Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy VolunteersFavipiravirPhase 1RecruitingInstitut National de la Santé Et de la Recherche Médicale, FranceSep 6, 2023
        A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaFavipiravirPhase 2RecruitingUniversity of OxfordDec 13, 2022
        Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)FavipiravirPhase 2RecruitingUniversity of OxfordSep 13, 2021
        AGILE (Early Phase Platform Trial for COVID-19)FavipiravirPhase 1 / Phase 2RecruitingUniversity of LiverpoolFeb 9, 2021

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4523676, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.